Showing results (1-10 of 223) with videos related to
Sort By:
Pageof 23
Current Hematologic Malignancy Reports|July 7, 2019
Overcoming Challenges in Process Development of Cellular TherapiesSteven L Highfill, David F StroncekJournal of Translational Medicine|January 16, 2022
Point-of-care cell therapy manufacturing; it's not for everyoneDavid F Stroncek, Robert P T Somerville, Steven L HighfillInternational Reviews of Immunology|April 29, 2022
Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapiesHannah W Song, Robert P Somerville, David F Stroncek, et al.Journal of Translational Medicine|January 26, 2018
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modulesJianjian Jin, Nikolaos Gkitsas, Vicki S Fellowes, et al.Transfusion|March 14, 2020
Group O plasma as a media supplement for CAR-T cells and other adoptive T-cell therapiesRandin C Nelson, Vicki Fellowes, Ping Jin, et al.Transfusion|April 12, 2019
Effects of starting cellular material composition on chimeric antigen receptor T-cell expansion and characteristicsNasha Elavia, Sandhya R Panch, Andrew McManus, et al.Journal of Translational Medicine|January 13, 2019
Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in cultureShutong Liu, David F Stroncek, Yingdong Zhao, et al.Current Opinion in Hematology|September 28, 2007
Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177David F StroncekJournal of Translational Medicine|November 25, 2021
High efficiency closed-system gene transfer using automated spinoculationVictoria Ann Remley, Jianjian Jin, Sarmila Sarkar, et al.Pageof 23